SPL 4.35% 8.8¢ starpharma holdings limited

Nintedanib - Nintedanib/Docetaxel - Nintedanib/DepDocetaxel, page-18

  1. 1,392 Posts.
    lightbulb Created with Sketch. 140
    Have I missed something? I thought we are still on target regarding everything. I don’t know what all the complaining is about. Pretty sure the staff at SPL aren’t just sitting on there hands counting the days until payday. Biotech takes time. Delays happen. Frustrating? Yes but I’m positive they are doing everything possible to get vivagel to market ASAP. I’m happy. Shorts are on the decrease, the share price has found a floor between 1.10 and 1.20 imo, so when that announcement that everyone’s been waiting for does come, I think it may start to run. Unless you are one of the poor sufferers of bv that is waiting to purchase a tube, I think everyone should just chill until our time comes. Gltah. Ps just keep in mind how long it takes to get a product like this to market and then think about the sales we will rack up until a competitor comes up with an alternative product and has to wait for it to get to market.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.